Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

leiomyosarcoma of the corpus uteri - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

leiomyosarcoma of the corpus uteri

MONDO:0016262

Also known as:Uterine Leiomyosarcomabody of uterus leiomyosarcomacorpus uteri leiomyosarcoma

Find Clinical TrialsTrials

Overview

An aggressive malignant smooth muscle neoplasm, arising from the uterine corpus. It is characterized by a proliferation of neoplastic spindle cells.

Clinical Trials9 registered · 4 recruiting

Diagnosis

Biomarker and diagnostic research for leiomyosarcoma of the corpus uteri has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

9 clinical trials registered, 4 recruiting. Interventions under study include drug therapy, procedural interventions, and other interventions. Pipeline includes 7 PHASE2, 1 NA. Research is primarily sponsored by academic and government institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT04727242](https://clinicaltrials.gov/study/NCT04727242)

Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 6:15 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:213625

GARD

Genetic and Rare Diseases Info Center

GARD:20477

Questions for Your Care Team

→Are any of the 9 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Patient case studies	39	33%
Research summaries	23	19%
Laboratory research	17	14%
Testing and diagnosis research	16	14%
Disease patterns and progression	10	8%
Clinical study results	5	4%
New treatment approaches	5	4%
Other research	3	3%

leiomyosarcoma of the corpus uteri

Overview

Diagnosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications